ArticleInsights into imaging2025
Early prediction of thyroid capsule invasion in papillary microcarcinoma using ultrasound-based deep learning models: a retrospective multicenter study.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
objectiveThyroid capsule invasion (TCI) predicts early progression in papillary thyroid microcarcinoma (PTMC). This study aimed to develop an integrated model that combines handcrafted peri-tumoral radiomics features with deep learning (DL)-derived intra-tumoral features for accurate early prediction of TCI, to support clinical decision-making. MATERIALS AND
methodsRetrospective data from 964 patients with 964 pathologically confirmed PTMC lesions across three centers were collected. Radiomics features were extracted from multiple peri-tumoral regions, and the optimal peri-tumor region with the best radiomics features was selected using a support vector machine (SVM). The selected radiomics features were then combined with intra-tumoral DL features extracted from the tumors before being fed into four different DL models for training and validation. Performance was validated on the internal (n = 177) and external (n = 84) test sets. Six radiologists (senior/attending/junior) assessed TCI with/without DL assistance.
resultsThe radiomics features, which achieved the best diagnostic performance with an AUC of 0.795 using SVM, were extracted from the peri-tumor region with 30% expansion from the original tumor. By further combining these radiomics features with intra-tumoral DL features, four different DL models were established to identify TCI in PTMC. Swin-Transformer achieved superior performance (internal AUC: 0.923; external AUC: 0.892). With DL model assistance, the AUCs of six radiologists significantly improved, for example, from 0.720 to 0.796 and from 0.725 to 0.790 for senior radiologists, and similar gains were observed for attending and junior radiologists.
conclusionsAs an effective clinical assistive tool, this integrated model can provide TCI identification with high level of accuracy. With its ability to enhance radiologists' diagnostic performance, it supports early PTMC risk stratification and personalized intervention. CRITICAL RELEVANCE STATEMENT: This retrospective multicenter study establishes an integrated model for identifying TCI in PTMC. The model significantly enhances radiologists' diagnostic precision across multiple experience levels, supporting early clinical decision-making for optimized intervention strategies. KEY POINTS: Accurate prediction of TCI facilitates early assessment of PTMC progression and guides subsequent individualized clinical management. DL significantly improves the predictive performance for TCI. DL effectively assists radiologists in TCI diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.